Thymalin is a preparation of low-molecular-weight polypeptides extracted from calf thymus, developed in the Soviet Union and still used clinically in Russia and neighboring states. It is not a single defined peptide, and that distinction matters more here than anywhere else in this compendium: the composition depends on the extraction, so two products under the same name are not necessarily the same thing.

There is a substantial literature, a few hundred papers, much of it reporting immunomodulatory and geroprotective effects. Almost all of it comes from a single research tradition, much of it is not in English, and the trial registry returns essentially nothing.

Proposed to restore thymic-dependent immune function by supplying thymic peptide signals, influencing T-lymphocyte differentiation and maturation.

Because the preparation is a mixture rather than a molecule, mechanism claims are harder to test than usual. Attributing an effect to a specific peptide requires isolating it, and the published work largely does not.

Difficult to assess honestly, and this entry is a good example of why that is a finding rather than a hedge.

Clinical reports exist, including long-running studies of elderly cohorts claiming effects on morbidity and survival. They come almost exclusively from one group of researchers in one country, are frequently published in journals that are hard to access or evaluate from outside, and have not been replicated independently.

That is not evidence that the claims are wrong. It is a statement that the usual mechanisms for checking them have not been applied. Anyone citing the survival findings should say where they come from.

Reported as well tolerated in the Russian clinical literature, at the doses and durations used there.

The specific risk here is not idiosyncratic toxicity, it is the preparation itself. An extract of animal tissue carries immunogenicity and contamination considerations that a synthetic peptide does not, and those depend entirely on manufacturing standards that are not verifiable from outside for gray-market product.

Registered as a medicine in Russia and some neighboring states. Not approved in the United States, the European Union, the United Kingdom or Australia.

Material sold internationally under this name is research-use-only, and given that the product is defined by its extraction rather than its structure, there is no straightforward way for a buyer to confirm it is the same preparation the literature describes.